Feb. 9 at 12:56 PM
$BDX
🚨 🚨 🚨
Adjusted Earnings Per Share (EPS):
$2.91, surpassing the estimated
$2.82.
Revenue:
$5.25 billion, exceeding the expected
$5.15 billion, with a 1.5% year-over-year increase.
Net Income:
$382 million, with reported profit of
$1.34 per share.
Outlook and Performance
Full-Year 2026 Guidance: BDX expects adjusted earnings in the range of
$12.35 to
$12.65 per share.
Segment Performance: The company is operating under a new segment structure as of October 1, 2025, which includes medical essentials, connected care, biopharma systems, interventional, and a life sciences segment.
